Leclercq I - Search Results

1

Reactive cholangiocytes differentiate into proliferative hepatocytes with efficient DNA repair in mice with chronic liver injury.

Manco R, Clerbaux LA, Verhulst S, Bou Nader M, Sempoux C, Ambroise J, Bearzatto B, Gala JL, Horsmans Y, van Grunsven L, Desdouets C, Leclercq I. Manco R, et al. Among authors: leclercq i. J Hepatol. 2019 Jun;70(6):1180-1191. doi: 10.1016/j.jhep.2019.02.003. Epub 2019 Feb 20. J Hepatol. 2019. PMID: 30794890

2

Fast determination of low-level cytochrome P-450 1A1 activity by high-performance liquid chromatography with fluorescence or visible absorbance detection.

Leclercq I, Desager JP, Vandenplas C, Horsmans Y. Leclercq I, et al. J Chromatogr B Biomed Appl. 1996 Jun 7;681(2):227-32. doi: 10.1016/0378-4347(95)00543-9. J Chromatogr B Biomed Appl. 1996. PMID: 8811431

3

The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat.

Leclercq I, Saliez A, Wallemacq PE, Horsmans Y, Lambotte L. Leclercq I, et al. Hepatology. 1997 Nov;26(5):1182-8. doi: 10.1002/hep.510260515. Hepatology. 1997. PMID: 9362360

4

Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

Leclercq I, Horsmans Y, Desager JP, Delzenne N, Geubel AP. Leclercq I, et al. J Hepatol. 1998 Mar;28(3):410-6. doi: 10.1016/s0168-8278(98)80314-0. J Hepatol. 1998. PMID: 9551678

5

Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.

Leclercq I, Desager JP, Horsmans Y. Leclercq I, et al. Clin Pharmacol Ther. 1998 Aug;64(2):144-9. doi: 10.1016/S0009-9236(98)90147-3. Clin Pharmacol Ther. 1998. PMID: 9728894

6

Estimation of chlorzoxazone hydroxylase activity in liver microsomes and of the plasma pharmacokinetics of chlorzoxazone by the same high-performance liquid chromatographic method.

Leclercq I, Horsmans Y, Desager JP. Leclercq I, et al. J Chromatogr A. 1998 Dec 18;828(1-2):291-6. doi: 10.1016/s0021-9673(98)00588-3. J Chromatogr A. 1998. PMID: 9916314

7

Dietary restriction of energy and sugar results in a reduction in human cytochrome P450 2E1 activity.

Leclercq I, Horsmans Y, Desager JP, Pauwels S, Geubel AP. Leclercq I, et al. Br J Nutr. 1999 Oct;82(4):257-62. Br J Nutr. 1999. PMID: 10655974

8

The compensatory hyperplasia (liver regeneration) following ligation of a portal branch is initiated before the atrophy of the deprived lobes.

Lambotte L, Li B, Leclercq I, Sempoux C, Saliez A, Horsmans Y. Lambotte L, et al. Among authors: leclercq i. J Hepatol. 2000 Jun;32(6):940-5. doi: 10.1016/s0168-8278(00)80098-7. J Hepatol. 2000. PMID: 10898314

9

Midazolam and cortisol metabolism before and after CYP3A induction in humans.

Eeckhoudt SL, Desager JP, Robert AR, Leclercq I, Verbeeck RK, Horsmans Y. Eeckhoudt SL, et al. Among authors: leclercq i. Int J Clin Pharmacol Ther. 2001 Jul;39(7):293-9. doi: 10.5414/cpp39293. Int J Clin Pharmacol Ther. 2001. PMID: 11471773 Clinical Trial.

10

Liver regeneration in obese mice with fatty livers: does the impairment have relevance for other types of fatty liver disease?

Farrell GC, Robertson GR, Leclercq I, Horsmans Y. Farrell GC, et al. Among authors: leclercq i. Hepatology. 2002 Mar;35(3):731-2. doi: 10.1053/jhep.2002.31786. Hepatology. 2002. PMID: 11870394 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters